Edition:
United Kingdom

Aratana Therapeutics Inc (PETX.OQ)

PETX.OQ on NASDAQ Stock Exchange Global Market

5.35USD
9:00pm BST
Change (% chg)

$0.07 (+1.33%)
Prev Close
$5.28
Open
$5.25
Day's High
$5.48
Day's Low
$5.23
Volume
44,513
Avg. Vol
70,333
52-wk High
$7.28
52-wk Low
$3.68

Consensus Recommendations

Consensus Recommendation Next Earnings (approx.) Company Fiscal Year
End Month
Last Updated
Outperform -0.02 December 15 Oct 2018

Analyst Recommendations and Revisions

1-5 Linear Scale Current 1 Month
Ago
2 Month
Ago
3 Month
Ago
(1) BUY 2 2 2 2
(2) OUTPERFORM 3 4 4 4
(3) HOLD 0 0 0 0
(4) UNDERPERFORM 0 0 0 0
(5) SELL 0 0 0 0
No Opinion 0 0 0 0
Mean Rating 1.60 1.67 1.67 1.67

Consensus Estimates Analysis

Sales and Profit Figures in US Dollar (USD)
Earnings and Dividend Figures in US Dollar (USD)
  # of Estimates Mean High Low 1 Year
Ago
SALES (in millions)
Quarter Ending Dec-18 5 16.13 22.90 7.10 15.28
Quarter Ending Mar-19 6 9.16 11.22 7.20 18.35
Year Ending Dec-18 5 29.89 38.06 20.52 42.47
Year Ending Dec-19 6 46.18 53.20 36.30 76.28
Earnings (per share)
Quarter Ending Dec-18 4 -0.02 0.16 -0.14 0.01
Quarter Ending Mar-19 5 -0.12 -0.06 -0.19 0.05
Year Ending Dec-18 5 -0.49 -0.29 -0.61 -0.44
Year Ending Dec-19 6 -0.28 -0.14 -0.52 -0.07

Historical Surprises

Sales and Profit Figures in US Dollar (USD)
Earnings and Dividend Figures in US Dollar (USD)
Estimates vs Actual Estimate Actual Difference Surprise %
SALES (in millions)
Quarter Ending Jun-18 5.06 4.91 0.15 2.99
Quarter Ending Mar-18 5.28 4.04 1.23 23.39
Quarter Ending Dec-17 6.82 10.46 3.64 53.33
Quarter Ending Sep-17 6.47 6.16 0.31 4.75
Quarter Ending Jun-17 4.72 5.16 0.43 9.16

Consensus Estimates Trend

Sales and Profit Figures in US Dollar (USD)
Earnings and Dividend Figures in US Dollar (USD)
  Current 1 Week
Ago
1 Month
Ago
2 Month
Ago
1 Year
Ago
SALES (in millions)
Quarter Ending Dec-18 16.13 16.13 16.13 15.04 15.28
Quarter Ending Mar-19 9.16 9.16 9.16 9.16 18.35
Year Ending Dec-18 29.89 29.89 28.45 28.45 42.47
Year Ending Dec-19 46.18 46.18 47.01 47.01 76.28

Estimates Revisions Summary

  Last Week Last 4 Weeks
Number Of Revisions: Up Down Up Down
Revenue
Quarter Ending Dec-18 0 0 0 0
Quarter Ending Mar-19 0 0 0 0
Year Ending Dec-18 0 0 0 0
Year Ending Dec-19 0 0 0 0
Earnings